Literature DB >> 12468195

ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002.

.   

Abstract

Polycystic ovary syndrome (PCOS) is a condition of unexplained hyperandrogenic chronic anovulation that most likely represents a heterogenous disorder. Its etiology remains unknown, and treatment is largely symptom based and empirical. Recent findings suggest PCOS has substantial metabolic sequelae, including risk of diabetes and possibly cardiovascular disease, and that primary treatment should focus on metabolic sequelae. The purpose of this document is to examine the best available evidence on the diagnosis and clinical management of PCOS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468195     DOI: 10.1016/s0029-7844(02)02628-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013

Review 2.  Polycystic ovary syndrome in adolescence.

Authors:  Colleen Buggs; Robert L Rosenfield
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

3.  Effects of drospirenone pill in Indian women with polycystic ovary syndrome.

Authors:  Sudhindra Mohan Bhattacharya; Mainak Ghosh; Nupur Nandi
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

Review 4.  Classification of menstrual bleeding disorders.

Authors:  Malcolm G Munro
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

5.  Effects of continuous versus cyclical oral contraception: a randomized controlled trial.

Authors:  Richard S Legro; Jaimey G Pauli; Allen R Kunselman; Juliana W Meadows; James S Kesner; Richard J Zaino; Laurence M Demers; Carol L Gnatuk; William C Dodson
Journal:  J Clin Endocrinol Metab       Date:  2007-12-04       Impact factor: 5.958

Review 6.  Functional obstructed voiding in the neurologically normal patient.

Authors:  Phillip P Smith; Rodney A Appell
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.